| Schedule of Computation of Basic and Diluted Earnings Per Share |
The following table presents the computation of Basic and Diluted EPS attributable to the Company’s common shares for the three and nine months ended September 30, 2026 and 2025:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, |
|
|
Nine months ended September 30, |
|
(in thousands, except for share and per share amounts) |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Numerator |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
78 |
|
|
$ |
4,554 |
|
|
$ |
(38,781 |
) |
|
$ |
5,296 |
|
Less: deemed dividends and accretion on preferred stock |
|
|
— |
|
|
|
(1,483 |
) |
|
|
(13,845 |
) |
|
|
(7,655 |
) |
Less: distributions to senior preferred unitholders |
|
|
— |
|
|
|
(583 |
) |
|
|
(1,226 |
) |
|
|
(1,750 |
) |
Less: Series A preferred stock dividends |
|
|
(582 |
) |
|
|
— |
|
|
|
(1,122 |
) |
|
|
— |
|
Income (loss) attributable to common stockholders - basic and diluted |
|
$ |
(504 |
) |
|
$ |
2,488 |
|
|
$ |
(54,974 |
) |
|
$ |
(4,109 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding - basic |
|
|
72,696,262 |
|
|
|
19,093,562 |
|
|
|
53,299,334 |
|
|
|
19,093,562 |
|
Dilutive shares |
|
|
— |
|
|
|
3,257,598 |
|
|
|
— |
|
|
|
— |
|
Weighted average common shares outstanding - diluted |
|
|
72,696,262 |
|
|
|
22,351,160 |
|
|
|
53,299,334 |
|
|
|
19,093,562 |
|
Net income (loss) per share, basic |
|
$ |
(0.01 |
) |
|
$ |
0.13 |
|
|
$ |
(1.03 |
) |
|
$ |
(0.22 |
) |
Net income (loss) per share, diluted |
|
$ |
(0.01 |
) |
|
$ |
0.11 |
|
|
$ |
(1.03 |
) |
|
$ |
(0.22 |
) |
|
| Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Earnings Per Share |
The table below presents the potentially dilutive securities excluded from the computation of Diluted EPS attributable to common stockholders because their inclusion would have been antidilutive or, for the earnouts, because the issuance conditions were not met, presented as a weighted average of the instruments outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, |
|
|
Nine months ended September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Stock awards |
|
|
4,309,776 |
|
|
|
— |
|
|
|
3,989,336 |
|
|
|
3,413,555 |
|
Warrants |
|
|
473,800 |
|
|
|
— |
|
|
|
303,718 |
|
|
|
— |
|
Series A preferred stock |
|
|
1,444,445 |
|
|
|
— |
|
|
|
931,217 |
|
|
|
— |
|
Contingently issuable shares - Earnouts |
|
|
1,264,027 |
|
|
|
— |
|
|
|
699,882 |
|
|
|
— |
|
|